New study validates the prognostic value of the HER2DX test in HER2-positive breast cancer
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—toget1
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—toget1
Iñaki Martín-Subero, head of the IDIBAPS Biomedical Epigenomics research group, has received a “Proof of Concept Grant” from the European Research Co1
Drs. Maria Carlota Londoño and Sabela Lens, hepatologists at Hospital Clínic and researchers in the Viral, Genetic and Immuno-mediated Liver Diseases1
CITOCAT was born with the aim of promoting research and dissemination of cytometry.
The study, led by IDIBAPS, also found that following a balanced diet can help prevent and reduce these symptoms.
IDIBAPS organises numerous outreach activities to bring research closer to the public. The aim is to publicise the work it carries out and to show th1
Once again this year, IDIBAPS has joined forced with 3cat’s La Marató telethon to organise open house visits to the public to show how scientific res1
A study by the Clínic-IDIBAPS concludes that left bundle branch pacing may be an effective and safe alterative to traditional biventricular pacing in1
Last May, Hospital Clínic Barcelona-IDIBAPS hosted the first face-to-face meeting of the European Network for Vascular Liver Diseases (EURO-VALDI-NET1
The Hospital Clínic Barcelona-IDIBAPS, together with the Hospital Sant Joan de Déu in Barcelona, is participating in the CrinGenES project, a pioneer1